https://www.selleckchem.com/products/nd-630.html
1-fold) and GBA-PD patients (by 1.6-fold) (p less then 0.0001 and p less then 0.0001, respectively). GD macrophage treatment resulted in increased GCase level and increased enzyme colocalization with the lysosomal marker LAMP2. The possible binding modes of ambroxol to mutant GCase carrying N370S amino acid substitution at pH 4.7 were examined using molecular docking and molecular dynamics simulations. The ambroxol position characterized by minimal binding free energy was observed in close vicinity to the residue, at position 370. Taken
Like
Comment
Share